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ABSTRACT 
Mitochondria are highly dynamic organelles in cells. They frequently change the morphology 
via continuous fission and fusion events, referred to as mitochondrial dynamics, which 
includes the shape, size and number of mitochondria in the cell, as well as mitochondrial 
subcellular distribution and mitochondrial quality control. Mitochondrial dynamics plays 
critical roles in sustaining the physiological functions of mitochondria. Dysfunction of 
mitochondrial dynamics is associated with various human diseases.  
Mitochondrial dynamics is mediated by a group of mitochondria-shaping proteins in yeast 
and in mammals. In yeast, the mitochondrial fusion mechanism consists of three central 
proteins, the inner membrane-anchored Mgm1p, and the outer membrane-anchored Fzo1p 
and Ugo1p. Correspondingly, Mfn1/2 (the homologs of Fzo1p) and OPA1 (the homolog of 
Mgm1p) are the core mitochondrial fusion proteins in mammals. On the mitochondrial 
fission side, the dynamin-related protein Dnm1p (in yeast)/Drp1 (in mammals) is a core 
component of the mitochondrial fission machinery, and the recruitment of cytosolic 
Dnm1p/Drp1 to the mitochondrial surface is the crucial step for mitochondrial division 
process. In yeast, Dnm1p is recruited to mitochondria by the mitochondrial receptor Fis1p via 
Mdv1p or Caf4p as the adaptor. However, in mammals, Fis1 (the homolog of yeast Fis1p) is 
not essential for the recruitment of Drp1 (the homolog of Dnm1p), although Fis1p and Fis1 
proteins are evolutionarily conserved and both can induce mitochondrial fragmentation when 
overexpressed. In agreement with this notion, overexpression or depletion of hFis1 does not 
affect Drp1 distribution in cells. Furthermore, no equivalents of Caf4p and Mdv1p have been 
found in mammalian cells to date. The functions of Fis1 in mammalian cells remain elusive. 
Instead, Mff and MIEF1/2 have been identified as new mitochondrial receptors for Drp1 in 
mammals. While the three receptors all can recruit Drp1 to mitochondria, whether they have 
distinct functions and how they work together in the mitochondrial fission process need to be 
further evaluated. In this thesis, we investigated the functions of Drp1 receptors Fis1, 
MIEF1/2 and Mff in mitochondrial dynamics of human cells and provide novel insights into 
the molecular mechanisms of human mitochondrial dynamics.  
In study I, we explored the distinct functions of MIEF1 and its paralog MIEF2. The 
similarities of MIEF1 and MIEF2 are: Both MIEFs share 45% amino acid identity in human 
cells and are highly conserved in vertebrates. They are anchored in the mitochondrial outer 
membrane (MOM), associate with Drp1 and recruit Drp1 from the cytosol to mitochondria, 
resulting in mitochondrial elongation. However, they are dissimilar in certain aspects. For 
example, their expression levels are different in human tissues and various cell lines, 
especially during organism development. Although overexpression of either MIEF1 or 
MIEF2 triggers mitochondrial elongation, MIEF2 overexpression induces a higher extent of 
elongated mitochondrial clustering and is reverted to a lower extent by hFis1 and Mff than 
MIEF1. Furthermore, MIEF1 and MIEF2 proteins form distinct types of oligomers in cells 
and contain different oligomerization domains. All of these data imply that the mitochondrial 
elongation factors MIEF1 and MIEF2 partly differ in their regulation of mitochondrial 
dynamics.  
In study II, we evaluated how Mff and MIEF1/2 coordinately work together in regulating 
Drp1-driven mitochondrial fission. Firstly, loss of MIEFs significantly impairs the 
association between Mff and Drp1, as well as the Drp1 recruitment by Mff to the 
mitochondrial surface, whereas knockdown of Mff does not affect the functions of MIEFs as 
mitochondrial Drp1 receptors. Secondly, MIEFs can bind to both Drp1 and Mff 
independently and serve as adaptors linking Drp1 and Mff together in a Drp1-MIEF-Mff 
trimeric complex, which facilitates the direct association between Drp1 and Mff. Thus, we 
find that MIEFs can promote the interaction of Drp1 with Mff. Furthermore, the relative 
amounts of MIEFs and Mff in cells govern the balance of mitochondrial dynamics. Enhanced 
levels of MIEFs decrease the interaction between Drp1 and Mff leading to mitochondrial 
elongation, while higher levels of Mff versus lower levels of MIEFs result in mitochondrial 
fragmentation. In sum, MIEFs and Mff work coordinately during Drp1-dependent 
mitochondrial fission, steering the balance between mitochondrial fission and fusion. 
In study III, we addressed the role of Drp1-S637 phosphorylation in Drp1 translocation from 
the cytosol to mitochondria and in the regulation of mitochondrial fission. Reversible Drp1-
S637 phosphorylation has been considered to regulate the Drp1-dependent mitochondrial 
fission and the recruitment of Drp1 to mitochondria, but the extent of this regulation is not 
fully understood. We confirm that Drp1 phosphorylation at S637 (Drp1-pS637) exists both in 
the cytosol and on mitochondria, and can be recruited and accumulated on mitochondria by 
MIEFs and Mff. Increased Drp1-pS637 does not affect the interaction between Drp1 and Mff 
whereas depletion of MIEFs decreases the binding of Mff with Drp1. Furthermore, similar to 
wild-type Drp1, overexpression of either phospho-deficient Drp1S637A or phosphomimic 
Drp1S637D mutants leads to mitochondrial fission in Drp1 deficient cells. However, 
Drp1S637D was less efficient than Drp1S637A and wild-type Drp1. Additionally, PKA, a 
kinase phosphorylating Drp1 at the S637 site, partially resides at the mitochondrial surface 
and is immunoprecipitated by MIEFs or Mff. However, PKA silencing does not abolish the 
Drp1-Mff or Drp1-MIEFs association. In brief, Drp1-S637 phosphorylation plays a fine-
tuning but not a dominant role in governing Drp1 subcellular distribution and Drp1-mediated 
mitochondrial fission, whereas Drp1 receptors MIEFs and Mff coordinately regulate the 
process of Drp1 recruitment and mitochondrial fission. 
In study IV, given a minor role of hFis1 in Drp1-dependent mitochondrial fission in human 
cells, we investigated the underlying molecular mechanism of hFis1-induced mitochondrial 
fragmentation and the roles of hFis1 in mitochondrial dynamics. Firstly, we observed that 
hFis1-induced mitochondrial fragmentation occurred both in presence and absence of Drp1 
and Dyn2, indicating mitochondrial fragmentation promoted by hFis1 is independent of the 
Drp1/Dyn2-medicated mitochondrial fission process. Furthermore, immunoprecipitation 
revealed that hFis1 binds to the pro-fusion proteins Mfn1, Mfn2 and OPA1 at endogenous 
levels and inhibits the GTPase activities of these proteins specifically, suggesting that the 
function of hFis1 is probably to block the fusion machinery and thereby shifting the balance 
to mitochondrial fission. Consistent with these results, destruction of all the three pro-fusion 
proteins in Drp1 KO cells phenocopied the hFis1-induced mitochondrial fragmentation 
phenotype, and the actin cytoskeleton was partially involved in this process. In conclusion, 
we reveal a novel molecular mechanism of hFis1 in mitochondrial dynamics.  
Collectively, this thesis develops novel insights into the molecular mechanisms of human 
mitochondrial dynamics, and provides more detailed knowledge for the studies of 
mitochondria-related diseases. 
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1 INTRODUCTION 
1.1 THE REGULATION OF MITOCHONDRIAL DYNAMICS 
Mitochondria as double membrane-bound organelles are present in most eukaryotic cells. 
They are traditionally considered to function as the powerhouses of the cell, generating 
adenosine triphosphate (ATP) through oxidative phosphorylation, used for cellular chemical 
energy. Mitochondria have their own genome, also known as mitochondrial DNA (mtDNA), 
which encodes some essential polypeptides of complexes I, III, IV and V in the oxidative 
phosphorylation system. Meanwhile, most mitochondrial proteins are encoded by nuclear 
DNA, synthesized in the cytoplasm, and imported to mitochondria (El-Hattab et al., 2017; 
Sun and St John, 2016; Taanman, 1999). In addition to producing ATP, mitochondria are also 
involved in regulating numerous aspects of cellular activity, including the cell-cycle 
progression and cell proliferation, the maintenance and differentiation of cells, mitophagy and 
autophagy, mitochondria-involved intrinsic cell-death pathway, transduction of calcium 
signaling, etc. Additionally, mitochondria are the major organelles generating and 
detoxicating reactive oxygen species (ROS) to adjust cellular redox homeostasis (McBride et 
al., 2006).  
Mitochondria themselves are highly dynamic and constantly alter their shape through fusion 
and fission events. The balance of fission and fusion events is termed mitochondrial 
dynamics, which is controlled by a number of mitochondria-shaping proteins encoded by 
nuclear genomic DNA. Not just related to mitochondrial morphology, mitochondrial 
dynamics also involves the size, number, distribution, quality control and transport of 
mitochondria in cells. Activated fission and/or inhibited fusion can lead to fragmented 
mitochondria, whereas active fusion and/or inhibited fission can cause mitochondrial 
elongation (Altieri, 2018; Chen and Chan, 2009; Senft and Ronai, 2016). Over the last 
decades, increasing data indicate that deregulation of mitochondrial dynamics causes 
mitochondrial dysfunction, impacting on a broad range of cellular functions, and is associated 
with a number of human diseases (Altieri, 2018; Chan, 2012; Chen and Chan, 2017; Mishra 
and Chan, 2014; Roy et al., 2015; Trotta and Chipuk, 2017; Zhao et al., 2013a).  
In this review, I will discuss how mitochondrial fusion and fission is regulated by the 
mitochondria-shaping proteins, and by other co-factors such as the endoplasmic reticulum 
(ER) and the actin-related cytoskeleton, as well as how mitochondrial dynamics influences a 
variety of cellular biological processes such as cell-cycle regulation, apoptosis, mitophagy, 
energy metabolism and embryonic development. 
1.1.1 The mitochondrial fusion machinery 
1.1.1.1 Key proteins of the mitochondrial fusion machinery in yeast 
Mitochondrial dynamics has been studied in yeast for many years. The mitochondrial fusion 
machinery characterized in yeast consists mainly of three key proteins, Fzo1p and Ugo1p, 
which are anchored in the mitochondrial outer membrane, and Mgm1p localized in the inner 
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membrane (listed in Table 1). Depleting any of these proteins results in mitochondrial 
fragmentation (Braun and Westermann, 2011; Merz et al., 2007; Shaw and Nunnari, 2002).  
Fzo1p, a large dynamin-related GTPase, is integrated in the MOM through two adjacent 
transmembrane sections near its C-terminus, and with a highly conserved N-terminal GTPase 
domain facing the cytoplasm. Fzo1p is requisite for fusion of the mitochondrial outer 
membrane (Hermann et al., 1998; Rapaport et al., 1998). Mgm1p is also a dynamin-related 
GTPase, with an N-terminal transmembrane domain anchored in the mitochondrial inner 
membrane, and a GTPase domain and two hydrophobic segments close to the C terminus, 
which are exposed in the intermembrane space. Mgm1p is required for both outer and inner 
mitochondrial membrane fusion, and the disruption of the MGM1 gene can result in 
mitochondrial fragmentation and loss of mtDNA in a Dnm1p-dependent fission (Sesaki et al., 
2003b; Wong et al., 2000; Wong et al., 2003). Both Fzo1p and Mgm1p are evolutionally 
conserved from yeast to humans. There are two homologs of Fzo1p in mammalian cells, 
termed mitofusin1 (Mfn1) and mitofusin2 (Mfn2), and the mammalian homolog of Mgm1p is 
known as OPA1 (Alexander et al., 2000; Santel and Fuller, 2001). 
Ugo1p was initially identified through the screening of yeast mutants that lost mtDNA in the 
Dnm1p-dependent division (Sesaki and Jensen, 2001). Ugo1p is a mitochondrial outer 
membrane-anchored protein and has three transmembrane domains in the middle region. The 
N-terminus faces the cytosol interacting with Fzo1p directly and the C-terminal domain is 
exposed to the intermembrane space for Mgm1p binding, thus Ugo1p has been viewed as a 
molecular bridge between Fzo1p and Mgm1p in mitochondrial fusion (Coonrod et al., 2007; 
Sesaki and Jensen, 2004). Ugo1p is required for both outer and inner mitochondrial 
membrane fusion (Hoppins et al., 2009), and loss of Ugo1p causes mitochondrial 
fragmentation (Sesaki and Jensen, 2001). In human cells, SLC25A46 has been found to have 
similar protein sequence with Ugo1p, but knockdown of SLC25A46 results in mitochondrial 
hyperfusion, indicating an opposite effect in human mitochondrial dynamics compared to 
Ugo1p in yeast (Abrams et al., 2015; Janer et al., 2016). Still some other proteins are also 
involved in the mitochondrial fusion process in yeast. For example, the F-box protein 
Mdm30p is essential for Fzo1p ubiquitylation and degradation after GTP hydrolysis in the 
late stage of outer membrane fusion for maintaining fusion-competent mitochondria in yeast, 
and this step requires Ugo1p (Anton et al., 2011; Cohen et al., 2011; Fritz et al., 2003). Pcp1p 
and Ups1p are required for the processing of Mgm1p to control mitochondrial morphology 
(Sesaki et al., 2006; Sesaki et al., 2003a).  
1.1.1.2 The mitochondrial fusion machinery in mammals 
In mammals, there are three key dynamin-like proteins controlling the mitochondrial fusion 
machinery, mitofusin 1 and 2 (Mfn1, Mfn2) and optic atrophy 1 (OPA1) (Table 1). All of 
them are large dynamin-related GTPases and their activation proceeds via a three-step 
mitochondrial fusion process: Two mitochondria are tethered and form a docking ring 
structure around the contact outer membranes,  further the two outer membranes fuse together 
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triggered by GTP hydrolysis, then coming to the inner membrane fusion (Brandt et al., 2016; 
Tilokani et al., 2018) (Figure 1). 
Both mammalian Mfn1 and its paralog Mfn2 reside in the outer mitochondrial membrane. 
They are homologs of Drosophila fzo, and similar to the fusion protein fzo1p in yeast. 
Human Mfn1 and Mfn2 share 60% identity and 77% similarity with each other in protein 
sequence. Both of them have a bipartite transmembrane domain, with both the N-terminal 
and C-terminal domains exposed towards the cytoplasm and GTPase domain close to the N-
terminus (Santel and Fuller, 2001). Overexpression of either Mfn1or Mfn2 can induce 
perinuclear mitochondrial clustering, whereas Mfn1/2-deficient cells contain severely 
fragmented mitochondria. Furthermore, Mfn1 and Mfn2 can form homo- and hetero-
oligomers, and these three complexes can work in concert to tether the outer mitochondrial 
membranes of adjacent mitochondria (Chen et al., 2003). In spite of that both proteins are 
essential for the maintenance of mitochondrial morphology, however, Mfn1 has much higher 
GTPase activity than Mfn2 (Ishihara et al., 2004). In addition to controlling mitochondrial 
morphology, Mfn2 has other distinct functions different from Mfn1. For instance, Mfn2 is 
involved in endoplasmic reticulum-mitochondria connections (de Brito and Scorrano, 2008), 
energy metabolism and insulin signaling (Zorzano et al., 2015), mitophagy (Chen and Dorn, 
2013) and apoptosis (Perumalsamy et al., 2010).  
OPA1 is the mammalian homolog of yeast Mgm1p, and is also a dynamin-related GTPase 
localized in the mitochondrial inner membrane acting in mitochondrial inner membrane 
fusion. OPA1 was originally discovered by gene mutation screening of autosomal dominant 
optic atrophy (Alexander et al., 2000). There are at least eight mRNA variants identified from 
the OPA1 gene through alternative splicing, generating long and short isoforms (Delettre et 
al., 2001). Further proteolytic cleavage can be performed by a group of proteases residing in 
the mitochondrial intermembrane space (e.g. PARL, PRELI, Yme1L, OMA1). Long forms of 
OPA1 undergo further processing in the matrix to produce short forms of OPA1, and both 
long and short forms of OPA1 complement each other to reconstitute the activity of 
mitochondrial fusion (Ishihara et al., 2006; Mishra et al., 2014; Song et al., 2007; Zhao et al., 
2013a). OPA1 processing can also be affected by mitochondrial membrane potential and 
proapoptotic stimuli. For example, Caspase-3 can lead to N-terminal cleavage of OPA1 
resulting in mitochondrial fragmentation (Loucks et al., 2009), and CCCP treatment is also 
known to induce cleavage of long OPA1 forms by OMA1 (Ehses et al., 2009; Head et al., 
2009). Knockdown of OPA1 causes mitochondrial fragmentation (Griparic et al., 2004), and 
overexpression of OPA1 induces mitochondrial elongation (Cipolat et al., 2004). Although 
Mfn1, Mfn2 and OPA1 all are essential for controlling mitochondrial fusion, overexpression 
of OPA1 can counteract the effect of Mfn2 knockout but not the effect of Mfn1 loss on 
mitochondrial morphology (Cipolat et al., 2004). This also confirms that there is a functional 
difference between Mfn1 and Mfn2. 
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1.1.2 The mitochondrial fission machinery 
1.1.2.1 The mitochondrial fission machinery in yeast 
In yeast, four key proteins are involved in the mitochondrial division process: Dnm1p, Fis1p, 
Mdv1p and Caf4p (Table 1). The dynamin-related GTPase Dnm1p is a central component of 
the mitochondrial fission machinery, which was initially discovered by screening yeast 
mutants with defective mitochondrial morphology (Bleazard et al., 1999; Otsuga et al., 1998). 
The re-localization of Dnm1p from the cytosol to mitochondria is the key step in 
mitochondrial fission. Fis1p acts as the mitochondrial receptor to recruit Dnm1p to the 
surface of mitochondria via one of the adaptors Mdv1p or Caf4p, acting as a protein bridge 
between Fis1p and Dnm1p. Then Dnm1p self-assembles around the mitochondrial surface 
forming spiral-like structures at constriction sites leading to scission of mitochondria (Griffin 
et al., 2005; Ingerman et al., 2005; Legesse-Miller et al., 2003; Tieu and Nunnari, 2000).  
Yeast GTPase Mammals GTPase 
Dnm1p + Drp1 + 
Fis1p - Fis1 - 
Mdv1p - -  
Caf4p - -  
-  MIEF1/2 -  
-  Mff - 
Vps1p + Dyn2 + 
Fzo1p + Mfn1/2 + 
Mgm1p + OPA1 + 
Ugo1p - SLC25A46 (just similar) - 
Fis1p is anchored in the MOM via the C-terminal tail and the N-terminal domain is facing the 
cytosol (Mozdy et al., 2000). The cytoplasmic domain of Fis1p contains a tetratricopeptide 
repeat (TPR) domain forming a concave surface, and a short N-terminal helix, which is 
required for recruiting and binding Mdv1p to the concave surface (Suzuki et al., 2005). Both 
Mdv1p and its paralog Caf4p are soluble cytosolic proteins containing an N-terminal 
extension (NTE), a middle coiled-coil domain, and a C-terminal WD repeat domain. Acting 
as molecular adaptors and bridge between Dnm1p and Fis1p, these proteins can bind to 
Dnm1p through the WD repeat domain and then associate with Fis1p through the NTE region 
(Griffin et al., 2005; Tieu et al., 2002). 
In Dnm1p-null cells, mitochondrial fission is blocked, mitochondria form long tubular 
appearances and mitochondrial membranes collapse to one side of the cell (Otsuga et al., 
1998). Fis1p-null mutation also causes mitochondrial reticular formation (Mozdy et al., 
2000). This indicates that both Dnm1p and Fis1p are critical for mitochondrial division in 
yeast. As to the two adaptors, in yeast cells with single Mdv1p-null or Caf4p-null mutant, 
mitochondrial morphology is similar to wild type, but in cells with double Mdv1p/Caf4p-null 
Table 1. Key mitochondria-shaping proteins in yeast and mammals 
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mutants, like in Fis1p-null mutant cells, mitochondria show elongated and net-like 
morphology, and most of Dnm1p stays in the cytoplasm. Interestingly, it was reported that 
overexpression of Mdv1p or Caf4p can inhibit mitochondrial fission as well. This may occur 
because overexpressed Mdv1p or Caf4p blocks the recruitment of Dnm1p to mitochondria 
(Cerveny and Jensen, 2003; Griffin et al., 2005). Additionally, Mdv1p and Caf4p also have 
distinct functions, for instance Mdv1p is more active than Caf4p in promoting fission, 
whereas Caf4p but not Mdv1p in association with Fis1p can determine the polarized 
localization of Dnm1p clusters on the mitochondrial surface after Dnm1p recruitment 
(Schauss et al., 2006). However, it was further reported that Fis1p is not essential for Dnm1p 
recruitment or mitochondrial membrane scission in yeast under a specified condition. Mdv1p 
contains an N-terminal extension (NTE) domain, that binds with Fis1p (Tieu et al., 2002). A 
truncated form of Mdv1p lacking NTE domain, fused with the transmembrane domain of 
Tom20, can be tethered to the outer mitochondrial membrane. This is sufficient to recruit 
Dnm1p to mitochondria and trigger fission in the absence of Fis1p (Koirala et al., 2013). 
1.1.2.2 The regulation of mitochondrial fission in mammals 
1.1.2.2.1 Drp1 and Dyn2 
In mammals, the regulation of mitochondrial fission is much more complicated than in yeast. 
The dynamin-related GTPase Drp1 is the ortholog of Dnm1p and shares 42% homology with 
Dnm1p (Pitts et al., 1999). Drp1-null MEFs (mouse embryo fibroblasts) or Drp1-knockdown 
HeLa cells show elongated mitochondrial appearance (Ishihara et al., 2009; Lee et al., 2004; 
Wakabayashi et al., 2009), which suggests that Drp1 is the central regulator of mitochondrial 
division in mammals like Dnm1p in yeast. Drp1 is primarily distributed in the cytoplasm, 
recruited by its four known receptors (Fis1, Mff, MIEF1/MiD51, MIEF2/MiD49, see Table 
1) from the cytoplasm to the mitochondrial surface, where Drp1 is assembled into higher-
order complexes that wrap around the mitochondrial surface to trigger mitochondrial fission 
through its GTPase activity (Otera et al., 2013). Another member of the dynamin-related 
family, Dynamin 2 (Dyn2) exists in cells ubiquitously, promoting the membrane remodeling 
of multiple organelles (Ferguson and De Camilli, 2012). Recently, it was reported that Dyn2 
is recruited to mitochondrial constrictions transiently after Drp1 puncta accumulation and 
works in the final step of mitochondrial division (Lee et al., 2016). In the fission process, 
Drp1 recruitment to mitochondria is a critical step, but the mechanisms underlying this 
process are not fully understood. A number of issues remain to be elucidated, for instance, 
why multiple mitochondrial receptors of Drp1 simultaneously exist in the cell, whether these 
receptors work independently of each other or in a coordinated pathway, how the post-
translational modifications of Drp1 impact on the process of mitochondrial division, etc.  
1.1.2.2.2 Fis1 and Mff 
Fis1 was the first identified receptor of Drp1 in mammals, and is the ortholog of the yeast 
Fis1p. hFis1 is localized to the outer mitochondrial membrane via its C-terminal TM domain, 
and the N-terminal region of hFis1 faces the cytosol (James et al., 2003; Yoon et al., 2003). 
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Overexpression of hFis1 promotes mitochondrial fission, resulting in extensively fragmented 
mitochondria (James et al., 2003; Yoon et al., 2003). However, several studies report that 
knockdown of Fis1 results in distinct mitochondrial morphologies in different cell lines. For 
example, in HeLa cells or in Fis1-null MEFs, absence of Fis1 can induce mitochondrial 
elongation (Arai et al., 2004; Lee et al., 2004; Loson et al., 2013), whereas knockdown of 
hFis1 in HCT116 cells does not affect mitochondrial morphology (Otera et al., 2010). 
Interestingly, it has been found that overexpression and knockdown of hFis1 does not affect 
the distribution of Drp1 in most human cells. For instance, elevated levels of hFis1 in 293T 
cells does not affect the subcellular distribution of Drp1 (Zhao et al., 2011). Likewise, 
knockdown of hFis1 in HeLa and HCT116 cells does not reduce levels of Drp1 on 
mitochondria (Lee et al., 2004; Otera et al., 2010). However, in Fis1-null MEFs, Drp1 puncta 
on mitochondria are reduced to some degree (Loson et al., 2013). Taken together, these 
studies suggest that Fis1 might have certain roles in some types of mammalian cells, whereas 
in other cell types it likely plays minor roles in Drp1-dependent mitochondrial fission. In 
spite of this fact, it is consistently found that overexpression of Fis1 can induce extensive 
mitochondrial fragmentation in all analyzed mammalian cells. This implies that Fis1-induced 
mitochondrial fission is likely at least under certain conditions involved in a Drp1-
independent fission pathway. Recent reports show that the GTPase regulator protein 
TBC1D15 binding to hFis1 but not to Drp1 may play an important role in the regulation of 
mitochondrial morphology (Onoue et al., 2013). TBC1D15 is the GTPase-activating protein 
of Rab7, which is recruited to mitochondria through the interaction between Fis1 and 
TBC1D15, and the Rab7-TBC1D15-Fis1 complex plays a role in mitochondrial fission 
(Wong et al., 2018). In normal conditions, the interaction between hFis1 and Drp1 is weak, 
but after treatment with different apoptotic or autophagic stimuli, an increased interaction 
between hFis1 and Drp1 is observed in cells accompanied with mitochondrial fragmentation 
(Ciarlo et al., 2010; De Palma et al., 2010; Kaddour-Djebbar et al., 2010; Shen et al., 2014; 
Zhao et al., 2011). These data indicate that hFis1 may have important functions in stress-
induced mitochondrial fission, whereas Mff is more likely to play a critical role in normal 
physiological Drp1-dependent mitochondrial division in mammals. Collectively, the 
mechanisms underlying hFis1-mediated mitochondrial fission are not fully understood so far. 
However, two reports suggest hFis1 has additional functions in controlling the association of 
MIEF1 with Drp1 via its direct interaction with MIEF1 to block MIEF1’s further binding to 
Drp1 (Zhao et al., 2011). Further supporting this hypothesis is that elevated levels of hFis1 
evidently can reduce the interaction between Drp1 and MIEF1 or MIEF2, respectively (Liu et 
al., 2013). 
Mff was primarily identified through small interfering RNA (siRNA) screening in 
Drosophila cells, and it exists in metazoans but not in yeast (Gandre-Babbe and van der 
Bliek, 2008). The Mff gene generates at least nine different isoforms by alternative splicing. 
Mff has a C-terminal transmembrane domain, by which it is anchored in the mitochondrial 
outer membrane, while its N-terminal region facing to the cytosol contains three short amino 
acid repeats (R1-R3 motifs) and a coiled-coil domain. The 50 N-terminal residues containing 
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R1 and R2 motifs are essential for Drp1 recruitment, and this is also the minimal region 
required for Drp1-Mff interaction (Gandre-Babbe and van der Bliek, 2008; Liu and Chan, 
2015; Otera et al., 2010). Knockdown of Mff  in HeLa cells by siRNA (Gandre-Babbe and 
van der Bliek, 2008; Otera et al., 2010) or knockout of Mff in MEFs (Loson et al., 2013) 
severely inhibits mitochondrial fission and abrogates Drp1 recruitment to mitochondria, 
whereas overexpression of Mff in HeLa cells induces extensive mitochondrial fission and 
recruits most of Drp1 from the cytosol to mitochondria (Otera et al., 2010). These findings 
suggest that Mff is the major receptor for Drp1 recruitment to mitochondria and thus actively 
acts in the mitochondrial fission process of mammals.  
1.1.2.2.3 MIEF1 and MIEF2 
MIEF1 and its paralog MIEF2 (also known as MiD51 and MiD49) are conserved vertebrate-
specific mitochondrial proteins (Zhao et al., 2013a). They were characterized by our group 
and by others as novel mitochondrial receptors for Drp1 recruitment to mitochondria (Liu et 
al., 2013; Palmer et al., 2011; Zhao et al., 2011). MIEF1 and MIEF2 are highly similar with 
respect to protein sequences, sharing 45% amino acid identity in human. Both of them have 
an N-terminal transmembrane domain anchoring them in the mitochondrial outer membranes 
(Liu et al., 2013; Palmer et al., 2011).  
In 293T and HeLa cells, expression of exogenous MIEF1 or MIEF2 consistently induces 
mitochondrial elongation. Both of these proteins can interact with and recruit Drp1 to 
mitochondria and distribute in a punctate manner on the mitochondrial surface (Liu et al., 
2013; Zhao et al., 2011). In Cos-7 cells, expression of exogenous MIEF1 or MIEF2 also leads 
to mitochondrial fusion and accumulation of Drp1 on mitochondria, however, at low levels of 
the protein, mitochondrial morphology is relatively normal (Palmer et al., 2011). Further 
studies show that longer-term expression of MIEF1 results in a variety of morphological 
changes of mitochondria from fragmentation to a network state, suggesting that low levels of 
exogenous MiD51/MIEF1 increase fission events, whereas at high expression levels, fission 
events are inhibited, resulting in opposing fusion (Elgass et al., 2015). On the other hand, 
knockdown of MIEF1 and MIEF2 by siRNA leads to inconsistent effects on mitochondrial 
morphology. It was reported that in Cos-7 monkey cells, knockdown of both MIEF genes is 
required to cause a mitochondrial fusion phenotype (Palmer et al., 2011), and another group 
found that in MEFs (mouse embryonic fibroblasts), knockdown of either of the two MIEF 
genes caused a similar mitochondrial fusion phenotype. Knockdown of both genes has been 
reported to induce mitochondrial elongation in Cos-7 cells and MEFs (Loson et al., 2013). 
However, it was also reported that in human HeLa cells, down-regulation of MIEF1 by 
siRNA resulted in mitochondrial fission (Zhao et al., 2011), while complete knockout of 
either MIEF alone, or double-knockout of both MIEF1/2 in HeLa cells caused mitochondrial 
elongation (Otera et al., 2016). The reason for these inconsistent results is currently unclear, 
but one possible explanation is that the relative levels of MIEFs in the cell can control the 
balance of mitochondrial fission and fusion differently depending on various cell types. It can 
be that the different cell types used for experiments have dissimilar endogenous levels of the 
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fission/fusion proteins and also are differentially regulated depending on cell type and 
physiological state. 
Furthermore, MIEF1 and MIEF2 are different in some aspects. Biochemical analysis shows 
that in addition to monomeric form, MIEF1 appears predominantly as dimers, whereas 
MIEF2 appears as oligomers. Importantly, the first 1-48 residues including the 
transmembrane domain are required for oligomerization of MIEF2, whereas the 
transmembrane domain is not crucial for dimerization of MIEF1. Additionally, MIEF1 and 
MIEF2 can form heterodimers (Liu et al., 2013). Moreover, their different crystal structures 
also indicate their distinct functions. Both proteins have a nucleotidyl transferase domain, but 
MIEF1 can bind nucleotide diphosphates (ADP and GDP), while MIEF2 does not, and 
MIEF1 binding to ADP can stimulate Drp1 oligomerization, self-assembly and its GTPase 
activity (Loson et al., 2014; Loson et al., 2015; Richter et al., 2014). Interestingly, treatment 
of MIEF1- or MIEF2- overexpressing cells with antimycin A, an inhibitor of complex III of 
the electron transport chain, leads to mitochondrial fragmentation in cells overexpressing 
MIEF1 but not in cells overexpressing MIEF2. Moreover, MIEF1-induced fission requires 
ADP binding to MIEF1 in this process (Loson et al., 2014; Loson et al., 2013).  
Although a large amount of effort has been devoted to understand the potential functions of 
MIEF1/2 in the regulation of mitochondrial dynamics, there are a number of questions to be 
further investigated. For example: (1) Whether MIEF1 and MIEF2 work together or they are 
involved in different steps during the Drp1 recruitment process; (2) Whether and how MIEFs 
work together with Mff or hFis1 during Drp1-dependent mitochondrial fission; (3) If the 
relative levels of the two MIEFs may affect the balance of mitochondrial fission and fusion; 
(4) How the potential post-translation modifications of these Drp1 receptors impact 
mitochondrial fission; (5) Whether they also play roles in other aspects of cellular 
physiology, besides mitochondrial dynamics. 
1.1.2.2.4 Drp1 phosphorylation and dephosphorylation 
In general, mitochondrial dynamics can be modulated by the amount, location and activity of 
mitochondria-shaping proteins and post-translational modifications of these proteins 
constitute important aspects for controlling the balance between mitochondrial fusion and 
fission. In a recent review, the different types of post-translational modifications occurring in 
the core mitochondria-shaping proteins have been presented, including phosphorylation, S-
nitrosylation, sumoylation, ubiquitination, tyrosine sulfation and acetylation (Pagliuso et al., 
2018; Willems et al., 2015). So far, Drp1 phosphorylation/dephosphorylation is the best 
studied and viewed as an important modification for the regulation of mitochondrial 
dynamics (Mishra and Chan, 2016; Tilokani et al., 2018). Here we will focus on how 
phosphorylation/dephosphorylation of Drp1 regulates mitochondrial fission. 
In human cells, phosphorylation/dephosphorylation of Drp1 occurs at two serine residues, 
S616 and S637, located at the junction of Drp1’s variable domain and GTPase effector 
domain (corresponding to human Drp1 isoform 1). These two sites are believed to have 
  9 
opposite effects on Drp1-driven mitochondrial fission. Drp1-S616 phosphorylation is 
regulated by CDK1/cyclin B during mitosis and leads to mitochondrial fragmentation 
(Taguchi et al., 2007). In contrast, Drp1-S637 is phosphorylated by cAMP-dependent protein 
kinase A (PKA), which inhibits the GTPase activity of Drp1, leading to mitochondrial 
elongation. Mutation of the S637 site to Asp (Drp1S637D) is believed to have similar effects as 
PKA stimulation. Additionally, Drp1 phosphorylated at the S637 residue can be 
dephosphorylated by calcineurin, promoting mitochondrial division (Chang and Blackstone, 
2007; Cribbs and Strack, 2007). Interestingly, it was reported that when using a double 
phosphomimetic Drp1 mutant Drp1S616D/S637D, the phosphorylation status of S637 was 
dominant over that of S616 in controlling the distribution of Drp1 in cells and the 
mitochondrial morphology (Cereghetti et al., 2008). Based on the results described above, it 
is believed that phosphorylation of Drp1 at S637 by PKA prevents its recruitment to 
mitochondria, thereby resulting in mitochondrial elongation, but a recent report shows that 
the Drp1 phosphomimetic mutant Drp1S637D is still recruited to mitochondria and interacts 
with Mff (Zhang et al., 2016). Moreover, a problem exists in that PKA is a multifunctional 
enzyme with a broad substrate specificity, therefore it cannot be excluded that PKA 
simultaneously affects the phosphorylation status of other mitochondria-shaping proteins, 
such as Mfn2 and OPA1 (Chang and Blackstone, 2010; Willems et al., 2015; Zhou et al., 
2010). Furthermore, the reversible phosphorylation and dephosphorylation of endogenous 
Drp1 is probably a dynamic process, while the phosphomimetic substitution lacks the 
dynamic aspects of endogenous phosphorylation in vivo as suggested (Chang and 
Blackstone, 2007).  
Furthermore, the mitochondrial scaffolding protein AKAP121 (A-kinase anchoring protein 
121) is also involved in Drp1 phosphorylation via translocation of PKA to the MOM, and 
controlling mitochondrial dynamics through PKA-modulated phosphorylation of Drp1 at 
S637. In line with this, knockdown of AKAP121 induces mitochondrial fragmentation, 
whereas overexpression of AKAP121 promotes mitochondrial elongation (Dickey and 
Strack, 2011; Merrill et al., 2011). These results are in agreement with the described effect of 
PKA stimulation. In addition, under hypoxia, AKAP121 together with Siah2 were described 
to inhibit Drp1-Fis1 interaction independently of PKA, inducing mitochondrial fission (Kim 
et al., 2011).  
In addition, the two serine residues S616 and S637 can be phosphorylated and 
dephosphorylated by different kinases and phosphatases. For example, the Drp1-S637 site 
can be phosphorylated by Ca2+/calmodulin-dependent protein kinase I α (CaMKIα), and this 
phosphorylation can stimulate mitochondrial fragmentation and increased affinity between 
Drp1 and hFis1 (Han et al., 2008). In neurons, protein phosphatase 2A (PP2A) also 
dephosphorylates Drp1 at S637 via its neuron-specific Bbeta2 regulatory subunit to cause 
mitochondrial fragmentation (Dickey and Strack, 2011). Similarly, multiple kinases have 
been found to be involved in the phosphorylation of Drp1 at S616 in addition to CDK1/cyclin 
B complex, for example, ERK1/2- and PKCδ-induced phosphorylation at S616 results in 
mitochondrial fragmentation under hyperglycemia and oxidative stress (Qi et al., 2011; Yu et 
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al., 2011), whereas CDK5-mediated phosphorylation at this serine residue reduces the 
activity of Drp1 and leads to mitochondrial elongation (Cho et al., 2014).  
Taking these data into account, it is not fully understood how the phosphorylation status of 
Drp1 promotes or inhibits mitochondrial fission. Whether individual kinases and 
phosphatases that regulate phosphorylation and dephosphorylation of Drp1 can also 
simultaneously affect the phosphorylation status of other mitochondria-shaping proteins 
needs to be clarified. 
1.1.3 The roles of the endoplasmic reticulum in mitochondrial dynamics  
The endoplasmic reticulum (ER) communicates with mitochondria through mitochondria-
associated ER membranes (MAMs) in yeast and mammals, and these connections have been 
shown to participate in different physiological functions, such as phospholipid synthesis, 
Ca2+-mediated signal transduction, protein import, mitochondrial distribution, mitophagy, and 
so on (de Brito and Scorrano, 2010; Lang et al., 2015; Murley et al., 2013). It is also reported 
that some of the mitochondria-shaping proteins are involved in this intercommunication. The 
mitochondrial profusion protein Mfn2 is localized on both mitochondria and the ER, and 
Mfn2 on the ER associates with Mfn1/2 on mitochondria and tethers the ER and 
mitochondria together to maintain the efficient mitochondrial Ca2+ uptake, which is essential 
for ATP production (de Brito and Scorrano, 2008).  
The ER has been also shown to play an active role in mitochondrial division. ER tubules 
were observed to wrap around mitochondria, mark the prospective sites of mitochondrial 
division and reduce the mitochondrial diameter by about 30% before Drp1 recruitment, 
which is to be followed by mitochondrial division, and the marked ER tubules mainly occur 
at positions of Drp1 and Mff foci. In fact, ER tubules also mark positions of mitochondrial 
constriction in the absence of Mff or Drp1 (Friedman et al., 2011). In addition to Drp1 and 
Mff, two other receptors of Drp1, MIEF1 and MIEF2, are also observed at mitochondria-ER 
contact sites, and co-localized with other fission proteins, such as Drp1 and Mff. However, 
less than 40% of observed mitochondria-ER contacts at MIEF foci are also constriction sites, 
implicating MIEFs are not the essential factors to determine ER-mitochondria constriction 
sites (Elgass et al., 2015). Furthermore, MIEFs require the presence of Drp1 to form foci, 
whereas Mff can form foci in cells lacking Drp1 (Friedman et al., 2011; Richter et al., 2014). 
Another known Drp1 receptor Fis1, has been shown in C. elegans to enter into a complex 
containing Drp1, Mff and ER proteins at the ER-mitochondrial interface during stimulation 
of mitophagy (Shen et al., 2014). However, it is still unclear if to what extent ER tubules are 
essential for mitochondrial fission and fusion. 
1.1.4 The roles of the actin cytoskeleton in mitochondrial dynamics  
Besides the ER, the actin cytoskeleton is also involved in regulating of mitochondrial fission 
(Moore and Holzbaur, 2018; Tilokani et al., 2018). The cycling of actin assembly and 
disassembly around mitochondrial subpopulations efficiently promotes local mitochondrial 
fission dependent on Drp1. However, inhibiting Drp1 activity by transfected with Drp1-
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K38A cannot affect actin cycling onto mitochondrial subpopulations as observed through 
live-cell imaging (Moore et al., 2016). Furthermore, some proteins related to the actin 
regulation play important roles in mitochondrial fission. An ER-localized actin regulator, 
INF2 (inverted formin 2) induces actin filaments to drive the initial mitochondrial 
constriction and then promotes Drp1 recruitment to ER-mitochondria constriction sites 
(Korobova et al., 2013). The isoform of the actin-nucleating protein Spire1C, localized to 
MOM, interacts with INF2, promoting actin assembly at the mitochondrial surface. 
Figure 1. The proposed models of mitochondrial fission and fusion in mammalian cells 
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Disturbing Spire1C or its formin-binding activities can affect the mitochondrial constriction 
and further mitochondrial fission (Manor et al., 2015). Myosin II also plays similar roles in 
mitochondrial fission. Myosin II enriches at mitochondrial constriction sites, and deletion of 
Myosin II reduces Drp1 accumulation on mitochondria (Korobova et al., 2014). Interestingly, 
Sept2 silencing also decreases the Drp1 association with mitochondria and increases the 
average distance between Drp1 clusters (Pagliuso et al., 2016). In addition, knockdown of 
actin-regulating factors cortactin, cofilin, and Arp2/3 complexes results in elongated 
mitochondria and disassembled mitochondrial F-actin around mitochondrial subpopulations 
(Li et al., 2015; Moore et al., 2016). In sum, it is a great challenge to understand how the ER, 
actin cytoskeleton and Drp1 receptors interplay and coordinate their actions to mediate 
mitochondrial division.  
Collectively, the proposed models of mitochondrial fission in mammalian cells are 
summarized in Figure 1. Mitochondria are pre-constricted by the ER, together with actin 
filaments associated with mitochondria by Spire1C and with ER by INF2. At the ER 
constriction site, Drp1 is recruited by its receptors to mitochondria and assembled to form 
higher-order oligomers around the mitochondrial surface. Then mitochondria are further 
constricted by Drp1 oligomers, and Dyn2 is recruited to the constricted site instantly to finish 
the scission of mitochondria through GTP hydrolysis. 
1.2 THE CROSSTALK BETWEEN MITOCHONDRIAL DYNAMICS AND 
CELLULAR BIOLOGICAL PROCESSES 
In living cells, mitochondria form a highly dynamic network, and continuously undertake 
fusion and fission changes. Though a very great deal of progress has been built on elucidating 
the molecular mechanisms that control mitochondrial morphology by mitochondria-shaping 
proteins in coordination with ER and actin-cytoskeleton, it is still poorly understood how 
mitochondrial dynamics and mitochondria-shaping proteins are mechanistically linked to 
mitochondrial functions and cellular biological processes. 
So far, accumulating evidence indicates that mitochondrial dynamics plays a crucial role in 
controlling mitochondrial functions. The carefully orchestrated the balance of mitochondrial 
fusion and fission is critical for keeping a healthy population and normal physiological 
functions of mitochondria. Fission allows the exclusion of damaged mitochondria via 
mitophagy and mitochondrial biogenesis, whereas fusion allows mitochondria to exchange 
their substance including proteins and mtDNA among individual mitochondria (Knott et al., 
2008). Abnormal mitochondrial dynamics is directly associated with mitochondrial 
dysfunction, thus impacting on a wide range of cellular processes, such as mitochondrial 
transport and biogenesis, cell-cycle regulation, cell proliferation and differentiation (Chen and 
Chan, 2009), energy metabolism, ROS production (Mishra and Chan, 2016; Willems et al., 
2015), Ca2+ signaling, mtDNA maintenance, apoptotic resistance of cells, mitochondrial 
quality control via autophagy (mitophagy), and ultimately programmed cell death, although 
the specific mechanisms are not clear (Mishra and Chan, 2014; Suen et al., 2008). Moreover, 
some important mitochondrial fission and fusion proteins have been established to be critical 
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for the embryonic development in mice (Chen et al., 2003; Chen et al., 2015; Davies et al., 
2007; Ishihara et al., 2009), further emphasizing that functions of mitochondrial dynamics go 
far beyond the appearance of mitochondria and have important physiological consequences. 
1.2.1 Mitochondrial dynamics and apoptosis 
Emerging data indicate that mitochondrial dynamics participates in the regulation of cell 
death pathways and remodeling of the mitochondrial network takes place in response to 
cellular stresses such as hypoxia, drug treatments and various pathological conditions. During 
apoptosis mitochondria undergo extensive fragmentation and some proteins of the 
mitochondrial fusion/fission machinery are directly involved in the regulation of apoptosis 
(Otera and Mihara, 2012; Suen et al., 2008). In general, elongated mitochondria confer 
cellular resistance to apoptosis, whereas fragmented mitochondria make cells sensitive to 
apoptotic stimuli (Chen and Chan, 2005; Suen et al., 2008). For example, knockdown of the 
pro-fission proteins hFis1 or Drp1 leads to mitochondrial elongation and resistance to 
different apoptotic stimuli, whereas depletion of the profusion proteins Mfn1, Mfn2 or OPA1 
leads to mitochondrial division and makes cells more sensitive to apoptosis (Otera and 
Mihara, 2012; Ugarte-Uribe and Garcia-Saez, 2014). In agreement with that mitochondrial 
dynamics regulates sensitivity of cells to apoptotic stimuli, it was previously reported that 
overexpression of MTGM/ROMO1 results in fragmented mitochondria and triggers a 
significant release of the death factor Smac/Diablo from mitochondria to the cytosol but no 
other death factors, for instance cytochrome c, AIF or Omi/HtrA2, and this did not lead to 
spontaneous apoptosis. However, down-regulation of MTGM results in elongated 
mitochondria and increases cell proliferation and the resistance of cells to apoptotic stimuli 
(Zhao et al., 2009). Furthermore, it was reported that MIEF1 and MIEF2 are also involved in 
the regulation of apoptosis. Expression of exogenous MIEF1 induces elevated autophagic 
activity and decreases the sensitivity of cells to apoptotic stimuli. Conversely, human cells 
depleted of MIEF1 are more sensitive to apoptotic stimuli (Zhao et al., 2011). However, loss 
of both MIEF1 and MIEF2 together with Mff in MEFs confers resistance to apoptosis 
(Osellame et al., 2016). Additionally, Drp1-dependent mitochondrial division controls cristae 
remodeling through MIEF1/2 during intrinsic apoptosis (Otera et al., 2016). Moreover, the 
OMM-associated E3 ubiquitin ligase MARCH5 coupled with MIEF2 controls Drp1-
dependent mitochondrial fission and cell sensitivity to stress-induced apoptosis (Xu et al., 
2016). Interestingly, MIEF1 is recently reported to regulate Bax translocation, and cells 
depleted of MIEF1 are sensitive to apoptotic stimuli and PINK1-Parkin-mediated mitophagy 
(Xian and Liou, 2019).  
In addition, mitochondrial outer membrane permeabilization (MOMP) is an important 
phenomenon closely coupled with pro-apoptotic stimuli. MOMP leads to the release of 
cytochrome c from mitochondria to the cytosol, in turn leading to activation of caspases and 
subsequent cell death. Although the precise mechanisms of MOMP remain to be elucidated, 
it is accepted that Bax and Bak are indispensable for this process (Wei et al., 2001). In 
healthy cells Bax is normally distributed predominantly in the cytosol, and during apoptosis, 
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Bax is translocated from the cytosol to the surface of mitochondria (Wolter et al., 1997), 
where Bax in coordination with Bak results in MOMP (Nechushtan et al., 2001). Several 
lines of evidence show that some mitochondria-shaping proteins participate in the Bax 
translocation. For example, hFis1 is required for translocation of Bax from the cytosol to the 
surface of mitochondria (Lee et al., 2004), Drp1 is required for activation and oligomerization 
of Bax (Montessuit et al., 2010; Wang et al., 2015), and OPA1 regulates cristae remodeling 
and triggers the release of cytochrome c to the cytosol (Mopert et al., 2009; Saita et al., 2016).  
It is generally accepted that one challenge of cancer therapy is the development of cancer 
resistance to chemotherapy and evading apoptosis constitutes one of the essential hallmarks 
of cancer, however, the machinery by which the resistance is developed in cancer still need 
be fully understood (Hanahan and Weinberg, 2000). Given the importance of mitochondrial 
dynamics in the regulation of cells resistance to apoptotic stimuli/ anticancer drugs, it is an 
important challenge to elucidate whether cancer cells can modify mitochondrial dynamics to 
thereby acquire resistance to anticancer drug treatment (Grandemange et al., 2009). 
Cumulative evidence is beginning to uncover a link between apoptotic resistance of cancer 
cells and abnormal mitochondrial dynamics. For instance, dysregulation of mitochondrial 
dynamics in lung cancer cells contributes to apoptotic resistance (Kawada et al., 2013; 
Rehman et al., 2012; Thomas and Jacobson, 2012). Treatments with different anticancer 
drugs can modify mitochondrial dynamics by regulating levels of mitochondria-shaping 
proteins in cancer (Lee et al., 2012; Tailor et al., 2013). The published data highlights the 
importance of mitochondrial dynamics in apoptotic resistance of cancer cells and in 
controlling life and death signals in cancer cells. 
In summary, mitochondrial fragmentation occurs in most forms of apoptosis through 
activation of the mitochondrial fission machinery and/or inhibition of the fusion machinery in 
various physiological and pathophysiological conditions. However, how this process is 
regulated and the precise mechanisms by which the mitochondria-shaping proteins involved 
in the apoptotic progression are largely unclear.  
1.2.2 Mitochondrial dynamics and mitophagy 
The mitochondrial quality control is executed through mitophagy, which selectively removes 
senescent or damaged mitochondria and balances the overall mitochondrial mass between 
biogenesis and degradation. Mitophagy is known to be regulated by Parkin and PINK1 
(PTEN-induced putative kinase protein 1) in mammals, and mutations in the genes encoding 
these proteins are associated with Parkinson’s disease (Gomes and Scorrano, 2012; Youle 
and Narendra, 2011). While Parkin normally exists in the cytosol, when cells lose the 
mitochondrial membrane potential, such as by CCCP treatment, PINK1 accumulates at the 
surface of impaired mitochondria and recruits Parkin from the cytosol to mitochondria. At the 
mitochondrial surface, Parkin, recruited by PINK1 to damaged mitochondria, ubiquitylates 
some mitochondrial proteins (e.g. Mfn1/2) and promotes damaged mitochondria to be 
engulfed by lysosomes (Sugiura et al., 2014; Youle and Narendra, 2011). There are a number 
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of Parkin substrates on the mitochondrial outer membrane and in the cytosol, which are 
ubiquitinated by Parkin (Martinez et al., 2017; Sarraf et al., 2013). The mitochondrial outer 
membrane protein Miro1 (Mitochondrial Rho GTPase 1), essential for mitochondrial 
transport (Schwarz, 2013), interacts with Parkin and functions as calcium-sensitive docking 
site of Parkin during mitochondrial damage. Knockdown of Miro1 reduces Parkin 
translocation to mitochondria and suppresses mitophagy (Safiulina et al., 2018).  
Growing evidence links mitochondrial dynamics with the regulation of mitophagy. The 
mitochondrial fusion factor Mfn2 was reported to mediate Parkin recruitment to damaged 
mitochondria. PINK1 can phosphorylate Mfn2, thereby promoting the translocation of Parkin 
to mitochondria and Parkin-mediated ubiquitylation of mitochondrial proteins. Loss of Mfn2 
prevents the translocation of Parkin to mitochondria (Chen and Dorn, 2013), and high levels 
of Fis1 are associated with mitochondrial dysfunction and trigger autophagy (Gomes and 
Scorrano, 2008). In addition, CCCP treatment induces mitochondrial fragmentation in 
general, however, cells lacking Fis1 and Mff are highly resistant to CCCP-induced 
mitochondrial fragmentation. Nevertheless, this resistance can be reversed through 
overexpression of MIEF1 or MIEF2 (Loson et al., 2013; Osellame et al., 2016; Xian and 
Liou, 2019; Zhao et al., 2011). These results indicate that mitochondria-shaping proteins play 
important roles in regulating mitophagy.  
1.2.3 Mitochondrial dynamics and cellular metabolism 
The biological impacts of mitochondrial dynamics are not restricted to the regulation of cell 
death pathways and mitophagy, but also involved in other cellular biological processes. The 
most common view is that mitochondria play important roles in cellular energy production, 
and it is believed that elongated mitochondria are more active and produce more energy, 
whereas short and fragmented mitochondria are weak and have reduced ATP production for 
cellular processes. This indicates that mitochondrial energy metabolism is coupled to 
mitochondrial dynamics. Accumulating evidence show that the mitochondria-shaping 
proteins, besides controlling mitochondrial fusion and fission events, are involved in cellular 
metabolism (Mishra and Chan, 2016; Roy et al., 2015). For example, Mfn2 was recently 
discovered to regulate cell metabolism and insulin signaling by limiting the production of 
ROS, and Mfn2 is considered to be a more important factor for energy metabolism than Mfn1 
(Zorzano et al., 2015). Another group also shows that ablation of both Mfn1 and Mfn2 in 
MEFs impairs ATP production and increases ROS production (Song et al., 2015). 
Furthermore, it was reported that Mfn2 regulates the expression of subunits that participate in 
OXPHOS complexes. Loss-of-function of Mfn2 reduces nuclear-encoded subunits of 
oxidative phosphorylation (OXPHOS) complexes I, II, III and V, whereas Mfn2 
overexpression increases the subunits of complexes I, IV and V (Pich et al., 2005). In 
addition to mitofusins, also OPA1 is involved in the regulation of mitochondrial energy 
status. The level of OXPHOS can regulate mitochondrial inner membrane fusion through 
Yme1L, which cleaves OPA1 more efficiently under high OXPHOS conditions to promote 
inner membrane fusion, while the mitochondrial outer membrane is insensitive to OXPHOS 
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levels (Mishra et al., 2014). As to fission proteins, Drp1 is the central factor for mitochondrial 
division, and it was discovered that knockdown of Drp1 by siRNA in HeLa cells decreases 
cellular ATP content and elevates ROS levels. In MEFs deleted of Drp1, however, the 
intracellular ATP levels and ROS production are normal (Ishihara et al., 2009; Song et al., 
2015; Wakabayashi et al., 2009). Additionally, MTGM/ROMO1 was previously discovered 
as a regulator of cellular ROS generation (Chung et al., 2006; Chung et al., 2008). 
In addition, an increasing amount of studies show that dysregulation of mitochondrial 
dynamics is involved in the shift towards ATP generation through glycolysis during cancer 
development (Corrado et al., 2012), and abnormal mitochondrial fission or fusion regulates 
migration and invasion of breast cancer cells (Zhao et al., 2013b). Moreover, the 
pathophysiology of metabolic diseases such as type 2 diabetes and obesity has been found to 
be associated with abnormalities in mitochondrial division and fusion. Several core 
mitochondria-shaping proteins, such as Drp1, OPA1 and Mfn2, have been discovered to be 
involved in these metabolic diseases (Roy et al., 2015). 
1.2.4 Mitochondrial dynamics and embryonic development  
During the development of embryos to adult individuals, mitochondria undergo a series of 
changes in quantity, size and morphology as they mature from an immature state. It has been 
reported that few mitochondria exist with poorly developed cristae and lower mitochondrial 
mass in blastocysts and embryonic stem cells, and after one-week differentiation, the 
resulting cells contain numerous larger tubular mitochondria with distinct cristae (Bavister, 
2006; Lonergan et al., 2007; St John et al., 2005).  
Mitochondria-shaping proteins have been shown to play essential roles in embryonic 
development of mice and human, emphasizing the significance of mitochondrial dynamics in 
embryonic development. For instance, mice deficient in the fusion-promoting proteins 
Mfn1/Mfn2 die in midgestation (Chen et al., 2003) and embryonic lethality occurs by 13.5 
days post coitum when lacking OPA1 (Davies et al., 2007). The fission-promoting factor 
Drp1 is essential for embryonic and brain development, and Drp1-null mice die at an early 
embryonic stage (Ishihara et al., 2009; Wakabayashi et al., 2009). Moreover, inhibition of 
Drp1-dependent mitochondrial division can impede myogenic differentiation and impair 
somatic cell reprogramming to pluripotent stem cells (Kim et al., 2013; Vazquez-Martin et 
al., 2012). In the two studies, a chemical inhibitor of Drp1, mdivi-1, has been used to block 
the functions of Drp1. These data imply that Drp1-dependent mitochondrial division is 
critical for myogenic differentiation and somatic cell reprogramming. Furthermore, it has 
been shown that MIEF1 and MIEF2, are differentially expressed in human fetal and adult 
tissues. MIEF1 mRNA was more abundant than MIEF2 in fetal tissues, while the MIEF2 
mRNA level was higher than the MIEF1 in adult tissues (Liu et al., 2013). Additionally, Mff-
deficient mice dye at 13 weeks by heart failure (Chen et al., 2015). Moreover, mitochondrial 
fusion is also necessary for cardiomyocyte differentiation. After ablation of Mfn1/2 or OPA1 
in embryonic mouse heart or mouse embryonic stem cells, heart development and 
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cardiomyocyte differentiation are arrested. Meanwhile, calcineurin-induced Ca2+ activity and 
Notch1 signaling activity are increased (Kasahara et al., 2013). Interestingly, Mfn2 is 
discovered to be specifically required for the maintenance of haematopoietic stem cells with 
extensive lymphoid potential based on the Ca2+ transmission through Mfn2 tethering of ER 
and mitochondria (Luchsinger et al., 2016). Based on the data mentioned above, it is 
suggested that both mitochondrial fusion and fission, as well as the respective regulatory 
proteins are likely important for the maintenance and differentiation of stem cells and for 
embryonic development. Therefore, it will be crucial for future research in regenerative 
medicine to elucidate how to control the differentiation of stem cells and embryonic 
development through manipulating mitochondrial dynamics. 
1.3 MITOCHONDRIAL DYNAMICS AND NEURODEGENERATIVE DISEASES 
Mitochondrial dysfunction leads to many pathological problems, and a number of studies are 
focusing on the relationship between mitochondrial dynamics and neurodegenerative 
diseases, such as Alzheimer’s disease (AD) (Corrado et al., 2012; Gao et al., 2017; Polanco et 
al., 2018; Qi et al., 2019; Wilson et al., 2013; Yoo and Jung, 2018). Neurodegenerative 
diseases are a group of disorders resulting in gradually progressive degeneration or death of 
neurons. In some hereditary neurodegenerative diseases, mitochondria-shaping proteins have 
been reported to play a critical role. For example, Charcot-Marie-Tooth neuropathy type 2A 
(CMT2A) is one type of peripheral neuropathies, which is associated with missense mutation 
of Mfn2 (Zuchner et al., 2004). Mutations of the OPA1 gene is found in a prevalent subset of 
autosomal dominant optic atrophy (ADOA) (Alexander et al., 2000). Till now, the treatment 
for neurodegenerative diseases is still a big challenge. 
AD is a chronic irreversible neurodegenerative disorder, characterized by the extracellular 
amyloid b (Ab) plaques and intraneuronal deposits of neurofibrillary tangles formed by 
protein tau aggregation. Ab is distributed normally in plasma and cerebrospinal fluid (CSF) 
(Shoji et al., 1992), and derived through secondary proteolytic cleavage by g-secretase 
complex from a 99aa C-terminal fragment (known as APP-C99) of amyloid precursor protein 
(APP), which is initially cleaved by b-secretase from the full-length APP (Portelius et al., 
2011; Takami et al., 2009). Abnormal ER-mitochondria associated membranes (MAM) have 
received considerable attention in AD, as g-secretase is highly active in the ER-mitochondria 
associated membranes, and Ab is produced at these sites including the mitochondrial outer 
membrane and mitochondria-associated ER membranes (Area-Gomez et al., 2009; Schreiner 
et al., 2015). There Ab aggregation increases the number of MAM points and mitochondrial 
calcium concentration (Hedskog et al., 2013). Additionally, the unprocessed APP-C99 is also 
enriched in ER-MAM in cells from AD patients, affecting the sphingolipid synthesis and 
hydrolysis (Pera et al., 2017). However, knockdown of Mfn2 decreases the production of Aβ 
(Leal et al., 2016). Furthermore, the contact sites between lysosomes and mitochondria are 
reported under physiological condition (Wong et al., 2018), but Ab oligomers, the precursors 
of amyloid plaques, are found to disrupt the crosstalk between mitochondria and lysosomes in 
the early stage of Alzheimer’s disease  (Norambuena et al., 2018). 
Alterations of mitochondrial structure are found in the brain tissues of AD patients, 
(Baloyannis, 2006; Hirai et al., 2001), and many sporadic mutations of the mtDNA occur in 
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AD patients (Coskun et al., 2004; Hirai et al., 2001). Drp1, as the key mitochondria-shaping 
GTPase, is reported to interact with Ab (Manczak et al., 2011) and phosphorylated tau 
(Manczak and Reddy, 2012). Now, Drp1 has been considered as one of the targets for the AD 
treatment. Mdivi-1 (Drp1 small molecular inhibitor) treatment decreases the extracellular Ab 
deposition, increases the production of ATP and rescues the dysfunction of mitochondria in 
AD cybrids (Gan et al., 2014; Wang et al., 2017). Furthermore, the levels of the 
mitochondrial fission proteins Drp1 and Fis1 are increased and the levels of the mitochondrial 
fusion proteins Mfn1, Mfn2, OPA1 are decreased in AD patients or cells compared with 
control (Manczak et al., 2011; Reddy et al., 2018). However, the roles of mitochondria-
shaping proteins in AD need to be further studied. Treatment targeting mitochondrial 
dysfunction in AD is the aim for the future. 
1.4 IN SUMMARY  
In the past twenty years, a great deal of progress has been built on identifying core 
components and regulatory factors of the mitochondrial fission/fusion machineries in 
mammals, and a considerable effort has been made in attempting to elucidate the potential 
molecular mechanisms that control and regulate mitochondrial fission and fusion events. This 
has provided us a number of new insights into the mechanisms of mitochondrial dynamics, 
and crosstalk with various cellular biological processes, embryonic development, numerous 
mitochondria-associated human diseases, as well as tumorigenesis and tumor progression. 
Although early studies believed that the mitochondrial fission and fusion machineries are 
evolutionarily conserved from yeast to human, it has become increasingly clear that these 
processes are much more complicated in mammalian cells than in single-cell yeast. The 
precise mechanisms and regulation of mitochondrial fission and fusion events are still largely 
unclear, and the relationship between mitochondrial dynamics and cellular biological 
processes as well as different human diseases needs to be further investigated. 
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2 PRESENT INVESTIGATION 
 
AIM OF THE STUDY 
 
The overall aim in this thesis was to investigate deeply the functions of the Drp1 receptors 
Fis1, MIEF1/2 and Mff in mitochondrial dynamics of human cells and further understand the 
molecular mechanisms of human mitochondrial dynamics. The four specific aims are to: 
1. Comparing the similarity and divergence of the human paralogs MIEF1 and MIEF2 in 
protein structures and functions. 
2. Investigating how MIEF1 and MIEF2 regulate mitochondrial fission and whether Mff 
and MIEFs have distinctive functions in the Drp1-mediated mitochondrial fission process. 
3. Elucidating the roles of Drp1 S637 phosphorylation status in regulating mitochondrial 
recruitment of Drp1 by MIEFs and Mff, and in Drp1-modulated mitochondrial fission. 
4. Investigating the underlying molecular mechanism of hFis1-triggered mitochondrial 
fragmentation in human cells. 
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3 RESULTS AND DISCUSSION 
3.1 STUDY I 
The mitochondrial elongation factors MIEF1 and MIEF2 play distinct roles in 
mitochondrial dynamics to some extent 
Dynamin-related protein 1 (Drp1) is a central GTPase in mitochondrial fission, and shifted 
from the cytosol to mitochondria, further resulting in mitochondrial fission. MIEFs (MIEF1 
and MIEF2) have been described as the major receptors of Drp1 in previous reports 
(Palmer et al., 2011; Zhao et al., 2011). Here we compare the functions of these two 
paralogs MIEF1 and MIEF2 in mitochondrial dynamics. 
3.1.1 Protein sequences of MIEFs and their expressions in human cell lines and tissues 
Similarities: 1) MIEF1 and MIEF2 are highly conserved in protein sequences, both 
contain C-terminal cytosolic part and a predicted N-terminal transmembrane domain 
localized in the mitochondrial outer membrane. 2) MIEF1 shares 45% sequence identity 
with MIEF2. 3) Both paralogs exist only in vertebrates and there are no homologs in 
yeast and invertebrates. 
Divergences: 1) The molecular masses of MIEF1 and MIEF2 are ~52 and ~49kDa 
separately determined from Western blotting. 2) They show distinct expression patterns 
in different human cancer cell lines, human fetal and adult tissues. In detail, expression 
of MIEF1 is relatively higher than MIEF2 in fetal tissues. In contrast, its expression is 
relatively lower than MIEF2 in adult tissues. 
3.1.2 The effects of wild-type MIEFs and their cytosolic mutants on mitochondrial 
morphology and interaction with Drp1  
Similarities: 1) Both the full-length MIEFs and their cytosolic mutants lacking 
transmembrane domains can bind to Drp1. However, the binding abilities of the cytosolic 
mutants are relatively lower than that of the full-length proteins. 2) Like wild-type MIEFs, 
the cytosolic mutants of MIEFs can also induce mitochondrial elongation when 
overexpressed.  
Divergences: Overexpression of MIEF1 results in large Drp1 aggregates on clustered 
mitochondria, while MIEF2 overexpression often leads to punctate accumulation of Drp1 
along elongated mitochondria. Moreover, MIEF2 induces a stronger fusion phenotype 
than MIEF1 at similar expression levels.  
3.1.3 Oligomer formation of MIEFs and the potential domains for oligomerization  
Similarities: MIEF1 and MIEF2 both can form homodimers and higher-order 
oligomers and they also interact with each other and form heterodimers.  
Divergences: 1) MIEF1 and MIEF2 have different domains that are responsible for the 
formation of their oligomers. The MIEF1 mutant lacking amino acids 109-154 is 
incapable of dimerization and higher-order oligomerization, whereas the first 49 amino 
acids of MIEF2 are essential for oligomerization. 2) Overexpression of either of these 
mutants without essential domains of oligomerization still induces mitochondrial 
elongation, and the MIEF1 mutant D109-154 interacts with Drp1 at the similar level as 
the wild-type control. 
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3.1.4 Roles of MIEFs in mitochondrial dynamics related to other Drp1 receptors 
Similarities: hFis1 and Mff have been recognized as Drp1 receptors also, and 
overexpression of either one causes the mitochondrial fission phenotype (Chan, 2012; 
Zhao et al., 2013a). Our data showed that both MIEF1 and MIEF2 have the ability to 
interact with hFis1. 
Divergences: Both hFis1 and Mff can reverse MIEF1- or MIEF2-induced mitochondrial 
fusion phenotype, but they are more efficient to counteract mitochondrial fusion induced 
by MIEF1 compared to MIEF2.  
So far, no homologs of MIEF1 and MIEF2 have been identified in yeast, which provides 
evidence of divergent evolution of functions in Drp1-dependent fission between yeast and 
vertebrates. Even though both MIEFs participate in Drp1-driven mitochondrial fission, they 
still have distinct functions to some extent, implicating that they may have divergent 
functions in cells. Furthermore, whether both MIEFs can coordinately work together for Drp1 
recruitment needs to be further elucidated.   
 
3.2 STUDY II 
MIEF1/2 function as adaptors for the initial Drp1 recruitment to mitochondria and 
regulate the association of Drp1 with Mff 
In mammalian cells, there are four mitochondrial outer membrane anchored proteins, Fis1, 
Mff, MIEF1 and MIEF2, which are responsible for recruitment of cytosolic Drp1 to 
mitochondria. Overexpression of hFis1 or Mff results in severe mitochondrial fragmentation 
(Gandre-Babbe and van der Bliek, 2008; James et al., 2003; Yoon et al., 2003), whereas 
overexpression of MIEF1 or MIEF2 leads to mitochondrial elongation, and further to the 
perinuclear mitochondrial clustering as described above. However, whether these 
mitochondrial receptors work together in a Drp1-dependent mitochondrial fission process is 
poorly understood. Here we investigated the underlying molecular mechanism of Drp1-
dependent mitochondrial fission controlled by MIEFs and Mff. 
3.2.1 MIEF1/2 in coordination with Mff act at distinct steps in the mitochondrial 
recruitment of Drp1 
Firstly, MIEFs have important roles in the initial recruitment of Drp1 to 
mitochondria and affect Mff-mediated recruitment of Drp1 to mitochondria. 
Immunofluorescence showed that depletion of MIEFs or Mff obviously decreased the 
Drp1 co-localization with mitochondria and induced mitochondrial elongation. However, 
simultaneous knockdown or knockout of both MIEFs, the Drp1 recruitment to 
mitochondria induced by Mff overexpression is significantly decreased. In contrast, 
knockdown of Mff by siRNA affected neither MIEFs-mediated recruitment of Drp1 to 
mitochondria nor the interaction between Drp1 and MIEFs. Additionally, cells without all 
of MIEFs and Mff exhibited further lower Drp1 co-localization with mitochondria. These 
data implied that even though both MIEFs and Mff have the ability to translocate Drp1 
from the cytosol to mitochondria, the Drp1 recruitment through Mff largely relied on the 
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existence of MIEFs. In contrast, Mff was dispensable for the MIEF-mediated Drp1 
recruitment. According to these results, we have suggested a model for this initial step of 
Drp1 recruitment (Figure 2a), in which MIEFs play a key role in the initial recruitment of 
Drp1 and depletion of MIEFs reduces Mff-driven recruitment of Drp1.  
Secondly, MIEF1/2 work as adaptors connecting Drp1 and Mff to form a Drp1-
MIEF-Mff triplex  
Confocal images combined with surface rendering revealed that Drp1, MIEF and Mff 
formed four patterns of co-localization at the mitochondrial surface: Drp1-MIEF, Drp1-
Mff, Drp1-MIEF-Mff and MIEF-Mff. Co-immunoprecipitation (co-IP) experiments and a 
sequential co-IP experiment proved the existence of these complexes. Using different 
Drp1 binding-deficient MIEFs (MIEF1D160-169, MIEF2D151-160) and Mff (MffD1-50) 
mutants subjected to co-IP experiments, we further revealed that MIEF functions as a 
molecular bridge linking Drp1 and Mff together in the trimeric complex, as exhibited in 
the schematic diagram Figure 2b. 
Next, endogenous MIEF1/2 promotes the direct association between Drp1 and Mff 
To compare the levels of the Drp1-Mff complex in wild-type and MIEF1&2 double-
knockout (MIEF-DKO) cells, we designed a set of experiments as follows. First, we 
immunodepleted endogenous MIEFs from wild-type 293T cells to remove three of the 
MIEF-related complexes (Drp1-MIEF, Drp1-MIEF-Mff and MIEF-Mff), then the 
supernatant together with the cell lysate of MIEF-DKO cells were subjected to co-IP with 
Mff antibody. Western blotting showed that the amount of Drp1-Mff complex in MIEF-
DKO cells was much less than in wild-type cells. This data implicates that endogenous 
MIEFs in wild-type cells facilitate the direct Mff-Drp1 interaction, as the model displays 
(Figure 2c). 
3.2.2 The relative levels of MIEFs mediate the balance of mitochondrial fusion and 
fission 
We next tested whether the different levels of Mff or MIEFs affect the association of 
Drp1 with MIEFs or Mff. Our results revealed that increased levels of MIEFs decreased 
Figure 2. Separate schematic diagrams for the steps of Drp1 recruitment from the cytosol to 
mitochondria. 1a, MIEFs have important roles in the initial recruitment of Drp1 to mitochondria. 
1b, MIEF1/2 work as adaptors to form a Drp1-MIEF-Mff triplex. 1c, the existence of endogenous 
MIEF1/2 promotes the direct association between Drp1 and Mff. 
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the association between Drp1 and Mff, whereas elevated expression of Mff reduced the 
interaction of MIEFs with Drp1. These data implied that Mff and MIEF competed the 
interaction with Drp1.  
Then we transfected MIEF-DKO cells with exogenous MIEF1 or MIEF2 to further 
explore the effect of different levels of MIEFs on mitochondrial morphology. We found 
that lower levels of exogenous MIEFs induced fragmented mitochondria, while cells with 
elongated mitochondria always had higher expressions of exogenous MIEFs. To further 
confirm these results, we knocked down endogenous MIEF1/2 by siRNA treatment in 
293T cells and re-introduced the mouse Mief1 or Mief2 cDNA. The similar results were 
observed as described in the above experiments. However, when we re-introduced mouse 
Mff cDNA to human 293T cells treated with Mff siRNA, mitochondrial fragmentation 
always occurs no matter of the expression levels of mouse Mff were high or low. These 
data suggested that higher levels of MIEFs prevent mitochondrial fission, whereas 
appropriate levels of MIEFs facilitate fission. 
Taken all together, in this study, we presented that Drp1 is recruited by MIEF together with 
Mff in a sequential and coordinated manner for Drp1-mediated mitochondrial fission, and the 
relative levels of MIEFs mediate the balance of mitochondrial fusion and fission. According 
to our results, we propose three models to explain how MIEFs and Mff mediate the balance 
of mitochondrial dynamics (Figure 3). When higher levels of MIEFs exist in cells, Drp1 is 
sequestered in Drp1-MIEF-Mff and/or Drp1-MIEF complexes, inhibiting the direct Drp1-Mff 
Figure 3. Schematic diagrams for different levels of MIEFs regulating mitochondrial dynamics  
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binding and resulting in mitochondrial fusion (Figure 3a). When MIEFs are maintained at 
moderate levels in cells, Mff can receive sufficient Drp1 via MIEFs action as a molecular 
bridge facilitating a direct interaction between Mff and Drp1 to maintain normal and balanced 
mitochondrial morphology (Figure 3b). However, in the absence of MIEFs, Mff cannot 
directly capture sufficient Drp1 from the cytosol by itself, thus the balance shifts to 
mitochondrial fusion, resulting in mitochondrial elongation (Figure 3c). 
 
3.3 STUDY III 
The Drp1-S637 phosphorylation status is not a determinant of Drp1 recruitment to 
mitochondria but fine-tunes mitochondrial fission  
Reversible phosphorylation of Drp1 has been implicated in the regulation of Drp1 
recruitment to mitochondria, but it is still poorly understood whether the phosphorylation 
status at S637 decides the subcellular localization and the fission activity of Drp1. In this 
study, we explore the potential roles of phosphorylation status at Drp1-S637 in the Drp1-
mediated fission activity, subcellular distribution of Drp1 and interactions of Drp1 with 
MIEFs or Mff.  
3.3.1 Phosphorylated Drp1-S637 (Drp1-pS637) is present both in the cytosol and on 
mitochondria  
The basal level of Drp1-S637 phosphorylation was low in 293T cells. We treated 293T 
cells with forskolin (PKA activator) or forskolin combined with FK506 (calcineurin 
inhibitor) to increase the relative level of Drp1-pS637. Confocal microscopy and 
subcellular fractionation analysis indicated that Drp1-pS637 was present both in the 
cytoplasm and at the mitochondrial surface. 
3.3.2 MIEFs and Mff recruit both Drp1-pS637 and non-phospho-Drp1-S637 to the 
surface of mitochondria  
Results from confocal imaging and subcellular fractionation analysis showed that, cells 
transfected with either MIEFs or Mff facilitate the obvious Drp1-pS637 accumulation on 
mitochondria.  
3.3.3 MIEFs and Mff bind to both Drp1-pS637 and non-phospho-Drp1-S637  
Co-IP results revealed that exogenous MIEFs or Mff interacted with Drp1-pS637. 
Similarly, endogenous Drp1-pS637 could also immunoprecipitate with endogenous 
MIEFs and Mff. In support of the results in the Study II, depletion of both MIEF1/2 
through siRNA largely diminished Mff interaction with Drp1-pS637 and total Drp1. 
3.3.4 Phosphorylation or dephosphorylation at S637 slightly affects but is not essential 
for governing the localization of Drp1 on mitochondria  
To further elucidate the potential role of Drp1 phosphorylation, we generated Drp1 
knockout 293T cells using CRISPR/Cas9-based genome editing technique and 
constructed untagged plasmids with wild-type Drp1 or with Drp1-S637D, Drp1-S637A 
mutants. Immunofluorescence showed that, like WT Drp1, the Drp1-S637D and Drp1-
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S637A mutants were localized to the cytosol and mitochondria. Overexpression of either 
Drp1-S637D or Drp1-S637A reversed the superfused mitochondria in Drp1-deficient 
cells to normal morphology. However, a significant difference was observed also: The 
phosphomimetic Drp1-S637D weakened Drp1-induced mitochondrial division. 
Furthermore, both Drp1-S637A and Drp1-S637D interact with MIEFs and Mff by co-IP 
experiments in Drp1-knockout and wild-type 293T cells. No obvious difference was 
found in interactions of MIEFs with exogenous WT Drp1, Drp1-S637A or Drp1-S637D 
in Drp1-knockout cells, but there was a slightly higher amount of the phospho-deficient 
Drp1-S637A and a lower amount of the phosphomimetic Drp1-S637D associating with 
Mff compared to WT Drp1.  
3.3.5 PKA also interacts with Mff and MIEFs, but is not a key regulator for the 
subcellular localization of Drp1 
Subcellular localization analysis and confocal imaging showed that PKA was present in 
both mitochondria and the cytosol. Co-IP showed that endogenous PKA was 
immunoprecipitated with MIEFs and Mff regardless the presence or absence of Drp1. 
Moreover, the absence of PKA did not affect the association of Drp1 with MIEFs and 
Mff, indicating that PKA is not a key modulator of Drp1 binding to MIEFs and Mff in 
cells. 
This study addressed the question whether the phosphorylation state of Drp1-S637 
determines Drp1 recruitment to mitochondria through its receptors Mff and MIEFs. Several 
previous publications consider that Drp1-S637 phosphorylation blocks mitochondrial 
recruitment of Drp1 and keeps it in the cytosol (Chang and Blackstone, 2007; Cribbs and 
Strack, 2007; Tilokani et al., 2018). In this study, our data indicated that phosphorylation or 
dephosphorylation of Drp1-S637 has a minor effect on mitochondrial recruitment of Drp1, 
and plays only a fine-tuning role for the fission activity of Drp1. 
 
3.4 STUDY IV 
An unanticipated function of human Fis1: inhibiting the mitochondrial fusion machinery 
Fis1 is a highly conserved MOM protein from yeast to humans. This protein was originally 
identified on mitochondria in yeast as Fis1p, where Fis1p functions as the Dnm1p receptor to 
captures cytosolic Dnm1p to mitochondria with the help of adaptors Mdv1p or Caf4p. In 
mammals, owing to the fact that overexpression of Fis1 promotes mitochondrial 
fragmentation, Fis1 was initially considered to be a mitochondrial fission factor and to work 
as the Drp1 receptor on mitochondria (James et al., 2003; Yoon et al., 2003). However, 
increasing evidence suggests that Fis1 is dispensable for Drp1 recruitment and Drp1-triggered 
mitochondrial division (Chan, 2012; Koirala et al., 2013; Shen et al., 2014). The molecular 
mechanism of Fis1-induced mitochondrial fragmentation is therefore poorly understood. Here 
we investigated the underlying mechanism of hFis1-induced mitochondrial fragmentation and 
the function of hFis1 in mitochondrial dynamics. 
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3.4.1 Mitochondrial fragmentation triggered by hFis1 overexpression is independent of 
Drp1 and Dyn2 
Both wild type and Drp1-knockout 293T cells transfected with hFis1 displayed 
mitochondrial fission morphology, this phenotype was also observed in HeLa cells with 
or without endogenous Drp1. Furthermore, depletion of Dyn2 by siRNA in wild type or 
Drp1-knockout 293T cells did not block hFis1-triggered mitochondrial fragmentation, 
implying that overexpression of hFis1 led to mitochondrial fragmentation in a way 
independent of fission proteins Drp1 and Dyn2. Moreover, the average size of punctate 
mitochondria induced by hFis1 overexpression in Drp1-knockout cells was larger and the 
total number of mitochondria was lower than in wild-type cells. This phenomenon is 
probably due to that additional mitochondrial fission still occurs by a Drp1-dependent 
manner in wild-type cells. 
3.4.2 hFis1 mainly interact with fusion proteins Mfn1/2 and OPA1 
Next, we examined whether hFis1 affected the mitochondrial fusion pathway instead of 
the fission machinery. First, loss of hFis1 in Drp1 knockout 293T cells resulted in 
superfused tubular clusters of mitochondria, located beside the nucleus. This was quite 
similar with the morphology observed in Drp1-knockout cells overexpressing any one of 
Mfn1/2 and OPA1. Furthermore, endogenous hFis1 is strongly associated with 
endogenous Mfn1/2 and OPA1 but no Drp1 and Dyn2. These results suggested that hFis1 
has a functional relationship with the mitochondrial fusion pathway. Moreover, we tested 
the specific regions of hFis1 protein that associated with Mfn1/2 and OPA1. Co-IP results 
revealed that the N-terminal part (containing TPR1 domain) is dispensable, while other 
parts of the hFis1 protein, including the C-terminal tail, TM and TPR2 domain, are 
required for binding to Mfn1/2 and OPA1.  
3.4.3 Human Fis1 disturbs the activity of mitochondrial fusion  
The PEG-induced cell fusion assay and a photoactivatable mtPA-GFP-based 
mitochondrial fusion assay were used to explore the extent and rate of mitochondrial 
fusion. Wild-type cells overexpressing hFis1 displayed decreased mitochondrial fusion 
activity compared with empty-vector transfected cells, whereas depletion of endogenous 
hFis1 by siRNA led to increased mitochondrial fusion when compared to control siRNA 
treatment. And similar results were discovered in Drp1-knockout 293T cells. These data 
suggest that overexpression of hFis1 impedes and knockdown of hFis1 promotes the 
activity of the mitochondrial fusion machinery irrespective of the presence or absence of 
Drp1. 
3.4.4 hFis1 impairs the activities of pro-fusion GTPases  
We tested the in vitro GTPase activity of Mfn1/2, OPA1, Drp1 and Dyn2 pre-incubated 
with or without hFis1 recombinant protein. The results from the GTPase activity assay 
showed that the presence of hFis1 recombinant protein significantly decreased the 
capacity of Mfn1/2 or OPA1 for GTP hydrolysis, but did not affect the GTPase activity of 
Drp1 and Dyn2, indicating that hFis1 primarily regulates the GTPase activity of the pro-
fusion proteins Mfn1/2 and OPA1 but not the pro-fission proteins Drp1 and Dyn2.  
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3.4.5 Destroying the fusion machinery phenocopies the hFis1-mediated mitochondrial 
fragmentation phenotype in Drp1 KO cells 
To further address the relationship between the fusion machinery and hFis1, we 
developed Drp1/OPA1 double-knockout cells using the CRISPR/Cas9 system, then 
knocked down either Mfn1, Mfn2, Mfn1&2, Dyn2, or Dyn2&Mfn1 by siRNA silencing, 
and combined with empty vector or Myc-hFis1 overexpression.  
Down-regulation of Mfn1 in Drp1/OPA1 double-knockout cells induced extensively 
fragmented mitochondria compared with control cells. After knockdown of both Mfn1 
and Mfn2, the number of cells with a fragmented mitochondrial phenotype was further 
increased, which is similar to that observed in the Drp1-knockout and Drp1/OPA1 
double-knockout cells overexpressing hFis1. These results suggest that destruction of the 
mitochondrial fusion machinery phenotypes mitochondrial fragmentation triggered by 
hFis1 overexpression.  
3.4.6 F-actin is involved in mitochondrial fission triggered by hFis1-overexpression in a 
Drp1-independent manner 
Drp1-knockout cells were transfected with exogenous hFis1 for 4h, followed by treatment 
with latrunculin B (LatB) for F-actin depolymerization or DMSO (control group). The 
number of cells with fragmented mitochondria in the LatB-treated group was reduced 
compared to the control group. These results implied that F-actin plays an important role 
in regulating mitochondrial fission in Drp1-KO cells overexpressing hFis1. 
In this study, we revealed novel functions of hFis1 in mitochondrial dynamics: hFis1-
triggered mitochondrial fragmentation is not due to hFis1 participating in the mitochondrial 
fission machinery but due to hFis1 inhibiting the activity of the mitochondrial fusion process, 
uncovering an unanticipated divergence in functional evolution from yeast to mammals. A 
schematic diagram is showed in Figure 4. 
  
Figure 4. The schematic diagram of human Fis1 inhibitory influence on the mitochondrial fusion 
machinery to regulate mitochondrial dynamics 
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4 CONCLUSION AND SIGNIFICANCE 
Drp1 recruitment from the cytosol to mitochondria is the central step of mitochondrial 
fission. In mammals, there are four receptors on mitochondria for Drp1 recruitment, Fis1, 
MIEF1/2 and Mff. In this thesis, we have investigated potential functions of these receptors 
in mitochondrial dynamics and the major findings are summarized as follows. 
Study I 
We demonstrated the refined functions of MIEF1 and MIEF2 in regulating mitochondrial 
dynamics.  
Similarities: 
• Overexpression of MIEF1 or MIEF2 captures Drp1 to the mitochondrial outer 
membrane and induces mitochondrial elongation.  
• Both MIEF1 and MIEF2 interact with Drp1 and hFis1. 
•  Both MIEFs can form higher-order oligomers.  
Differences: 
• MIEF2 has a more efficient effect on mitochondrial fusion and clustering than 
MIEF1.  
• MIEF2 has the opposite expression to MIEF1 in human fetal and adult tissues.  
• The essential domain of MIEF1 for oligomerization is amino acids 109-154, while 
MIEF2 requires amino acid residues 1-49.  
Consistent with our data, other researchers also reported the divergences of MIEF1 and 
MIEF2 in the crystal structures and functional analysis. In brief, MIEF1 uniquely binds 
ADP at the nucleotidyltransferase domain but MIEF2 does not, which is critical for Drp1 
assembly and GTP hydrolysis (Loson et al., 2014; Loson et al., 2015; Richter et al., 2014). 
However, the reason for these functional divergences needs to be further analyzed. 
Furthermore, our results also suggest that MIEF1 and MIEF2 may have additional 
functions besides in modulating mitochondrial dynamics, such as involving in 
mitochondrial diseases and embryonic developmental processes, which need to be 
investigated in the future. 
Study II 
The roles of MIEF1/2 and Mff in Drp1 recruitment to mitochondria were presented in detail:  
• MIEF1/2 collaborate with Mff step by step to mediate Drp1 recruitment to 
mitochondria and balance mitochondrial morphology.  
• MIEF1/2 serve as the adaptors connecting Drp1 with Mff, and promotes the 
formation of a dimeric Drp1-Mff complex.  
The paradoxical phenomenon that both overexpression and depletion of MIEFs induced 
mitochondrial fusion while overexpression of Mff led to mitochondrial fission is explained. 
Owing to the existence of a Drp1-MIEF-Mff triple complex, the relative expression levels of 
MIEFs control the balance between mitochondrial fusion and fission.  
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• Higher levels of MIEFs sequester Drp1 in Drp1-MIEF and Drp1-MIEF-Mff 
complexes, preventing the direct Drp1-Mff binding, and resulting in mitochondrial 
elongation. Consistent with this, another study also showed that MIEF1 substantially 
inhibits Drp1 GTPase activity with or without the presence of Mff (Osellame et al., 
2016).  
• When the levels of MIEFs or the relative levels between MIEFs and Mff are 
moderate, the two proteins work cooperatively for Drp1-dependent mitochondrial 
division, then the mitochondrial phenotype is normal or fragmented.  
• In the absence of MIEFs, endogenous Mff does not have the capacity to capture 
sufficient Drp1 by itself, resulting in the balance shifting to mitochondrial fusion. This 
is the reason why mitochondria present an elongated morphology in the absence of 
MIEFs.  
Study III 
We refined the roles of Drp1 phosphorylation in Drp1-driven mitochondrial division. 
• Phosphorylation or dephosphorylation of Drp1-S637 is not a major factor determining 
the subcellular distribution and fission activity of Drp1. Regardless whether Drp1 is 
phosphorylated or not, both of them can be recruited to mitochondria by MIEFs and 
Mff.  
• The phosphorylation status of Drp1-S637 is involved in the fine-tuning of Drp1-
dependent mitochondrial division although it is not important for regulating the 
subcellular localization of Drp1.  
Post-transcriptional modifications, especially phosphorylation and dephosphorylation of Drp1 
have attracted a lot of attention for their potential roles in the regulation of mitochondrial 
dynamics in the past years. Although it has been reported that phosphorylation levels of Drp1 
S637 are increased in some diseases (Park et al., 2019; Xie et al., 2015), the potential 
mechanisms of diseases related to these aspects of mitochondrial dynamics need to be further 
elucidated. 
Study IV 
This study, as it is highlighted recently (Liesa et al., 2019), uncovers the molecular 
mechanisms of Fis1-triggered mitochondrial fragmentation by inhibiting mitochondrial 
fusion and open an exciting new area of research in mammals, and also highlights the 
limitation of categorizing mitochondrial dynamics proteins, given the general tendency to 
associate fragmentation with activation of fission. 
• Surprisingly, instead of its association with the pro-fission GTPases in the 
mitochondrial fission pathway, hFis1 mainly associates with pro-fusion GTPases.  
• hFis1-triggered mitochondrial fragmentation occurred by inhibiting the functions of 
the pro-fusion GTPases resulting in a shift of balance to mitochondrial fission.  
• Human Fis1 plays multiple roles in mitochondrial dynamics, which is significantly 
divergent from the functions of its homolog Fis1p in yeast.  
Finally, according to the published literature and our results, I suggest that there are multiple 
potential pathways to drive mitochondrial fission in mammals (Figure 5): 
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Drp1-dependent fission pathway: 
• It is generally considered that Drp1 plays a critical role in mitochondrial fission. 
Controlling its recruitment from the cytosol to mitochondria is a key step in this 
process. Thus, Drp1 and its mitochondrial receptors/adapters including Mff, MIEF1/2 
and Fis1 are the major components of the canonical mitochondrial fission pathway, in 
which Drp1 is recruited to the ER/actin constriction sites on mitochondria by one of 
these mitochondrial receptors/adapters or in a way by which MIEFs and Mff 
coordinately work to govern Drp1 recruitment, and subsequently Drp1 assembles into 
higher-order oligomers to wrap around mitochondria, and ultimately the Drp1-
mediated mitochondrial membrane scission occurs with the help of Dyn2 recruited 
transiently to the division sites (Described also in Figure 1). 
Drp1-independent fission pathways: 
Accumulating data suggest that apart from the canonical Drp1-dependent pathways, there are 
likely additional pathways that also contribute to mitochondrial fission in mammalian cells.  
• As presented in the Study IV, Fis1 binds to Mfn1/2 or OPA1 and inhibits the 
mitochondrial fusion machinery in Drp1-deficient cells, shifting mitochondrial 
morphology to a fission phenotype. Especially, the size of the punctiform 
mitochondria induced by hFis1 overexpression in Drp1 KO cells was larger than in 
wild-type cells, which we believe is attributed to the ongoing Drp1-triggered 
mitochondrial fission in wild-type cells. These data suggest that the Drp1-dependent 
mitochondrial fission pathway is probably parallel with the Fis1-mediated inhibition 
to the mitochondrial fusion machinery, and they work together to shift mitochondrial 
dynamics to fission. 
• In addition to the function we reported, other studies also found that Fis1 together 
with TBC1D15 and Rab7 is involved in mitochondrial fission. In detail, 
overexpression of Fis1 and TBC1D15 (a Rab GTPase regulator protein) induced 
mitochondrial fission in Drp1-deficient MEFs, and Fis1 binds to TBC1D15 (Onoue 
et al., 2013). Recently it is found that the small GTPase Rab7 is associated with the 
Fis1-TBC1D15 complex via mitochondria-lysosome contacts, which regulates both 
mitochondrial and lysosomal dynamics (Wong et al., 2018). Furthermore, increasing 
evidence related to TBC1D15 and Rab7 implicates that this complex may play 
important roles in mitophagy (Rojansky et al., 2016; Tan and Tang, 2019; Yamano 
et al., 2018). In this aspect, the exact molecular mechanism is unknown. 
• The ER and actin cytoskeleton are also reported to be involved in mitochondrial 
dynamics (Friedman et al., 2011; Korobova et al., 2013; Moore and Holzbaur, 2018). 
In the Study IV, we have presented that F-actin depolymerization significantly 
prevented hFis1 overexpression-induced mitochondrial fragmentation in a Drp1-
independent manner, implying that actin plays an important role in regulating 
mitochondrial fission independent of Drp1. Furthermore, even now the ER is 
considered as the first step of Drp1-mediated mitochondrial fission, mediating 
mitochondrial constriction before Drp1 recruitment (Friedman et al., 2011), whether 
the ER induces mitochondrial scission directly independent of Drp1 needs to be 
further studied. 
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• Although Dyn2 has been reported to work at the final step of Drp1-dependent 
mitochondrial division (Lee et al., 2016), mitochondrial division still occurs in Dyn2-
deficient cells (Kamerkar et al., 2018). In the Study IV, we found that Dyn2 
knockdown reversed the mitochondrial division phenotype that was induced when 
both fission and fusion machineries had simultaneously been destroyed, indicating 
that Dyn2 may have own pathways for mitochondrial fission when the canonical 
Drp1-mediated pathway is blocked. 
Figure 5. The supposed molecular mechanisms in mitochondrial fission 
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